Coherus Biosciences Inc

NASDAQ:CHRS  
14.16
-0.22 (-1.53%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.06B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$91.79 Million
Adjusted EPS-$0.16
See more estimates
10-Day MA$14.06
50-Day MA$14.07
200-Day MA$16.62
See more pivots

Coherus Biosciences Inc Stock, NASDAQ:CHRS

333 Twin Dolphin Drive, Suite 600, Redwood City, California 94065
United States of America
Phone: +1.650.649.3530
Number of Employees: 317

Description

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.